ConductScience.org, home

Library / Genes

CD209: CD209 molecule

1 protein, 75 patents, 0 drugs, 0 trials, 4,128 NIH grants and 7,809 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolCD209HGNC
NameCD209 moleculeHGNC
NCBI Gene ID30835NCBI Gene
HGNC IDHGNC:1641HGNC
EnsemblENSG00000090659NCBI Gene
AliasesCDSIGN, CLEC4L, DC-SIGN, DC-SIGN1, hDC-SIGNNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q9NNX6CD209 antigen40414Ensembl, GeneID, HGNCUniProt

Patents 75

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1440496Q9NNX6Espacenet
JP 2025529142 A2025-09-04789Q9NNX6Espacenet
US 12371689 B22025-07-29789Q9NNX6Espacenet
WO 2025093745 A12025-05-0892Q9NNX6Espacenet
US 12290535 B22025-05-0611Q9NNX6Espacenet
WO 2025061682 A12025-03-277Q9NNX6Espacenet
EP 4494652 A22025-01-22178Q9NNX6Espacenet
EP 4392022 A22024-07-0316Q9NNX6Espacenet
US 12023385 B22024-07-0217Q9NNX6Espacenet
JP 2023123739 A2023-09-05178Q9NNX6Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4128

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P01AI106695Protective immunity following dengue virus natural infections and vaccination202,025NIH's project files
P30CA008748Cancer Center Support Grant142,025NIH's project files
P51OD011132Emory National Primate Research Center142,025NIH's project files
P30AI050409Center for AIDS Research at Emory University132,025NIH's project files
P30CA016672Cancer Center Support Grant122,025NIH's project files
R01AI022553Molecular Analysis of Host Immune Response in Leprosy122,025NIH's project files
P51OD011104Tulane National Primate Research Center112,025NIH's project files
T32AI007290Molecular and Cellular Immunobiology112,025NIH's project files
P30AI027757University of Washington/Fred Hutch Center for AIDS Research102,025NIH's project files
R01AR040312CD1-restricted T-cell Responses in Skin102,025NIH's project files

Papers 7809

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42819061PubTator, text miningPubMed
42818626PubTator, text miningPubMed
42815045PubTator, text miningPubMed
42812399PubTator, text miningPubMed
42805952PubTator, text miningPubMed
42796407PubTator, text miningPubMed
42770795PubTator, text miningPubMed
42764681PubTator, text miningPubMed
42759193PubTator, text miningPubMed
42747892PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license